Imatinib for the treatment of refractory, diffuse systemic sclerosis
Gespeichert in:
| Veröffentlicht in: | Rheumatology (Oxford, England) England), 2008-05, Vol.47 (5), p.735-737 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 737 |
|---|---|
| container_issue | 5 |
| container_start_page | 735 |
| container_title | Rheumatology (Oxford, England) |
| container_volume | 47 |
| creator | Sfikakis, P. P. Gorgoulis, V. G. Katsiari, C. G. Evangelou, K. Kostopoulos, C. Black, C. M. |
| description | |
| doi_str_mv | 10.1093/rheumatology/ken104 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_195659255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rheumatology/ken104</oup_id><sourcerecordid>1468009071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-8b234a61f7a5969fd03fc66f984d7527cdd244286a1bf6aef66881d0c2d6f443</originalsourceid><addsrcrecordid>eNqNkM1Kw0AURgdRrFafQJDBtWnnP8lSq7WFii4KFjfDJJmxaZtOnZmAeXsjKdWlq3sX3_nu5QBwhdEAo5QO3VLXlQp2Yz-a4VpvMWJH4AwzQSJEKTk-7IT1wLn3K4QQxzQ5BT2cUCI4JWfgYdpWlNsyg8Y6GJYaBqdVqPQ2QGug08apPFjX3MKiNKb2GvrGB12VOfT5RjvrS38BTozaeH25n30wHz_OR5No9vI0Hd3NopwlcYiSjFCmBDax4qlITYGoyYUwacKKmJM4LwrCGEmEwpkRShshkgQXKCeFMIzRPrjpanfOftbaB7mytdu2FyVOueAp4bwN0S6Ut6_59n-5c2WlXCMxkj_e5F9vsvPWUtf76jqrdPHL7EW1gUEXsPXun41RB5Stra8DotxaipjGXE4W73K2eBP3Y_Qqn-k3hgeN2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195659255</pqid></control><display><type>article</type><title>Imatinib for the treatment of refractory, diffuse systemic sclerosis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Sfikakis, P. P. ; Gorgoulis, V. G. ; Katsiari, C. G. ; Evangelou, K. ; Kostopoulos, C. ; Black, C. M.</creator><creatorcontrib>Sfikakis, P. P. ; Gorgoulis, V. G. ; Katsiari, C. G. ; Evangelou, K. ; Kostopoulos, C. ; Black, C. M.</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/ken104</identifier><identifier>PMID: 18326532</identifier><identifier>CODEN: BJRHDF</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Benzamides ; Female ; Humans ; Imatinib Mesylate ; Piperazines - therapeutic use ; Protein Kinase Inhibitors - therapeutic use ; Pyrimidines - therapeutic use ; Scleroderma, Diffuse - drug therapy</subject><ispartof>Rheumatology (Oxford, England), 2008-05, Vol.47 (5), p.735-737</ispartof><rights>The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2008</rights><rights>The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-8b234a61f7a5969fd03fc66f984d7527cdd244286a1bf6aef66881d0c2d6f443</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1579,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18326532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sfikakis, P. P.</creatorcontrib><creatorcontrib>Gorgoulis, V. G.</creatorcontrib><creatorcontrib>Katsiari, C. G.</creatorcontrib><creatorcontrib>Evangelou, K.</creatorcontrib><creatorcontrib>Kostopoulos, C.</creatorcontrib><creatorcontrib>Black, C. M.</creatorcontrib><title>Imatinib for the treatment of refractory, diffuse systemic sclerosis</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Adult</subject><subject>Benzamides</subject><subject>Female</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Piperazines - therapeutic use</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Pyrimidines - therapeutic use</subject><subject>Scleroderma, Diffuse - drug therapy</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkM1Kw0AURgdRrFafQJDBtWnnP8lSq7WFii4KFjfDJJmxaZtOnZmAeXsjKdWlq3sX3_nu5QBwhdEAo5QO3VLXlQp2Yz-a4VpvMWJH4AwzQSJEKTk-7IT1wLn3K4QQxzQ5BT2cUCI4JWfgYdpWlNsyg8Y6GJYaBqdVqPQ2QGug08apPFjX3MKiNKb2GvrGB12VOfT5RjvrS38BTozaeH25n30wHz_OR5No9vI0Hd3NopwlcYiSjFCmBDax4qlITYGoyYUwacKKmJM4LwrCGEmEwpkRShshkgQXKCeFMIzRPrjpanfOftbaB7mytdu2FyVOueAp4bwN0S6Ut6_59n-5c2WlXCMxkj_e5F9vsvPWUtf76jqrdPHL7EW1gUEXsPXun41RB5Stra8DotxaipjGXE4W73K2eBP3Y_Qqn-k3hgeN2g</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Sfikakis, P. P.</creator><creator>Gorgoulis, V. G.</creator><creator>Katsiari, C. G.</creator><creator>Evangelou, K.</creator><creator>Kostopoulos, C.</creator><creator>Black, C. M.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20080501</creationdate><title>Imatinib for the treatment of refractory, diffuse systemic sclerosis</title><author>Sfikakis, P. P. ; Gorgoulis, V. G. ; Katsiari, C. G. ; Evangelou, K. ; Kostopoulos, C. ; Black, C. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-8b234a61f7a5969fd03fc66f984d7527cdd244286a1bf6aef66881d0c2d6f443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Benzamides</topic><topic>Female</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Piperazines - therapeutic use</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Pyrimidines - therapeutic use</topic><topic>Scleroderma, Diffuse - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sfikakis, P. P.</creatorcontrib><creatorcontrib>Gorgoulis, V. G.</creatorcontrib><creatorcontrib>Katsiari, C. G.</creatorcontrib><creatorcontrib>Evangelou, K.</creatorcontrib><creatorcontrib>Kostopoulos, C.</creatorcontrib><creatorcontrib>Black, C. M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sfikakis, P. P.</au><au>Gorgoulis, V. G.</au><au>Katsiari, C. G.</au><au>Evangelou, K.</au><au>Kostopoulos, C.</au><au>Black, C. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imatinib for the treatment of refractory, diffuse systemic sclerosis</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2008-05-01</date><risdate>2008</risdate><volume>47</volume><issue>5</issue><spage>735</spage><epage>737</epage><pages>735-737</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><coden>BJRHDF</coden><cop>England</cop><pub>Oxford University Press</pub><pmid>18326532</pmid><doi>10.1093/rheumatology/ken104</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1462-0324 |
| ispartof | Rheumatology (Oxford, England), 2008-05, Vol.47 (5), p.735-737 |
| issn | 1462-0324 1462-0332 |
| language | eng |
| recordid | cdi_proquest_journals_195659255 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
| subjects | Adult Benzamides Female Humans Imatinib Mesylate Piperazines - therapeutic use Protein Kinase Inhibitors - therapeutic use Pyrimidines - therapeutic use Scleroderma, Diffuse - drug therapy |
| title | Imatinib for the treatment of refractory, diffuse systemic sclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T11%3A42%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imatinib%20for%20the%20treatment%20of%20refractory,%20diffuse%20systemic%20sclerosis&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Sfikakis,%20P.%20P.&rft.date=2008-05-01&rft.volume=47&rft.issue=5&rft.spage=735&rft.epage=737&rft.pages=735-737&rft.issn=1462-0324&rft.eissn=1462-0332&rft.coden=BJRHDF&rft_id=info:doi/10.1093/rheumatology/ken104&rft_dat=%3Cproquest_cross%3E1468009071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195659255&rft_id=info:pmid/18326532&rft_oup_id=10.1093/rheumatology/ken104&rfr_iscdi=true |